The Journal of Thoracic and Cardiovascular Surgery
Volume 136, Issue 3 , Pages 688-696 , September 2008

Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 years

Received 12 November 2007 ,Revised 28 March 2008 ,Accepted 13 May 2008.

References 

  1. Roselli EE, Smedira NG, Blackstone EH. Failure modes of the Carpentier–Edwards pericardial bioprosthesis in the aortic position. J Heart Valve Dis. 2006;15:421–428
  2. Scully H, Goldman B, Fulop J, Butany J, Tong C, Azuma J, et al. Five-year follow-up of Hancock pericardial valves: management of premature failure. J Card Surg. 1988;3(3 Suppl):397–403
  3. Leandri J, Bertrand P, Mazzucotelli JP, Loisance D. Mode of failure of the Mitroflow pericardial valve. J Heart Valve Dis. 1992;1:225–231
  4. Banbury MK, Cosgrove DM, Thomas JD, Blackstone EH, Rajeswaran J, Okies JE, et al. Hemodynamic stability during 17 years of the Carpentier–Edwards aortic pericardial bioprosthesis. Ann Thorac Surg. 2002;73:1460–1465
  5. Minami K, Zittermann A, Schulte-Eistrup S, Koertke H, Körfer R. Mitroflow synergy prostheses for aortic valve replacement: 19 years experience with 1,516 patients. Ann Thorac Surg. 2005;80:1699–1705
  6. Pomar JL, Jamieson WR, Pelletier LC, Gerein AN, Castella M, Brownlee RT. Mitroflow pericardial bioprosthesis: clinical performance to ten years. Ann Thorac Surg. 1995;60(2 Suppl):S305–S310
  7. Yankah CA, Weng Y, Meyer R, Siniawski H, Hetzer R. Twenty-two–year durability of Ionescu–Shiley pericardial aortic bioprosthesis implanted in a 49-year-old woman: a valuable insight into the performance of current pericardial bioprostheses. J Thorac Cardiovasc Surg. 2006;132:427–428
  8. Yankah CA, Schubel J, Buz S, Siniawski H, Hetzer R. Seventeen-year clinical results of 1,037 Mitroflow pericardial heart valve prostheses in the aortic position. J Heart Valve Dis. 2005;14:172–180
  9. Moggio RA, Pooley RW, Sarabu MR, Christiana J, Ho AW, Reed GE. Experience with the Mitroflow aortic bioprosthesis. J Thorac Cardiovasc Surg. 1994;108:215–220
  10. Sjögren J, Gudbjartsson T, Thulin LI. Long-term outcome of the MitroFlow pericardial bioprosthesis in the elderly after aortic valve replacement. J Heart Valve Dis. 2006;15:197–202
  11. Thulin LI, Thilen UJ, Kymle KA. Mitroflow pericardial bioprosthesis in the aortic position. Low incidence of structural valve deterioration in elderly patients during an 11-year follow-up. Scand Cardiovasc J. 2000;34:192–196
  12. Cosgrove DM, Lytle BW, Williams GW. Hemodynamic performance of the Carpentier–Edwards pericardial valve in the aortic position in vivo. Circulation. 1985;72(3 Pt 2):II146–II152
  13. Garcia-Bengochea J, Sierra J, Gonzalez-Juanatey JR, Rubio J, Vega M, Fernandez AL, et al. Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis. J Heart Valve Dis. 2006;15(3):446–452
  14. David TE, Puschmann R, Ivanov J, Bos J, Armstrong S, Feindel CM, et al. Aortic valve replacement with stentless and stented porcine valves: a case–match study. J Thorac Cardiovasc Surg. 1998;116:236–241
  15. Sintek CF, Fletcher AD, Khonsari S. Small aortic root in the elderly: use of stentless bioprosthesis. J Heart Valve Dis. 1996;5(Suppl 3):S308–S313
  16. Westaby S, Jin XY, Katsumata T, Arifi A, Braidley P. Valve replacement with a stentless bioprosthesis: versatility of the porcine aortic root. J Thorac Cardiovasc Surg. 1998;116:477–484
  17. Frater RW, Furlong P, Cosgrove DM, Okies JE, Colburn LQ, Katz AS, et al. Long-term durability and patient functional status of the Carpentier–Edwards Perimount pericardial bioprosthesis in the aortic position. J Heart Valve Dis. 1998;7:48–53
  18. Jamieson WR, David TE, Feindel CM, Miyagishima RT, Germann E. Performance of the Carpentier–Edwards SAV and Hancock-II porcine bioprostheses in aortic valve replacement. J Heart Valve Dis. 2002;11:424–430
  19. Minami K, Schereika S, Kortke H, Gleichmann U, Koerfer R. Long term follow-up of Mitroflow pericardial valve prostheses in the small aortic annulus. J Cardiovasc Surg (Torino). 1993;34:189–193
  20. Rao V, Jamieson WR, Ivanov J, Armstrong S, David TE. Prosthesis–patient mismatch affects survival after aortic valve replacement. Circulation. 2000;102(19 Suppl. 3):III5–III9
  21. Borger MA, Ivanov J, Armstrong S, Christie-Hrybinsky D, Feindel CM, David TE. Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis. 2006;15:49–55discussion 55-6
  22. Khan SS, Trento A, DeRobertis M, Kass RM, Sandhu M, Czer LS, et al. Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg. 2001;122:257–269
  23. Legarra JJ, Llorens R, Catalan M, Segura I, Trenor AM, de Buruaga JS, et al. Eighteen-year follow up after Hancock II bioprosthesis insertion. J Heart Valve Dis. 1999;8:16–24
  24. Smedira NG, Blackstone EH, Roselli EE, Laffey CC, Cosgrove DM. Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration of allograft and pericardial prostheses. J Thorac Cardiovasc Surg. 2006;131:558–564e4
  25. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36:1152–1158
  26. Butchart EG, Moreno de la Santa P, Rooney SJ, Lewis PA. Arterial risk factors and ischemic cerebrovascular events after aortic valve replacement. J Heart Valve Dis. 1995;4:1–8
  27. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg. 1996;112:708–711
  28. Nollert G, Miksch J, Kreuzer E, Reichart B. Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement. J Thorac Cardiovasc Surg. 2003;126:965–968
  29. Puvimanasinghe JP, Takkenberg JJ, Edwards MB, Eijkemans MJ, Steyerberg EW, Van Herwerden LA, et al. Comparison of outcomes after aortic valve replacement with a mechanical valve or a bioprosthesis using microsimulation. Heart. 2004;90:1172–1178
  30. Blackstone EH, Kirklin JW. Death and other time-related events after valve replacement. Circulation. 1985;72:753–767

 Charles Yankah reports consulting and lecture Fees From Sorin.

PII: S0022-5223(08)00876-3

doi: 10.1016/j.jtcvs.2008.05.022

The Journal of Thoracic and Cardiovascular Surgery
Volume 136, Issue 3 , Pages 688-696 , September 2008

Article Tools

* Image Usage & Resolution